The biopharmaceutical company develops and manufactures medicines concerning a range of illnesses, including asthma, pain, cancer, and infectious diseases.
Looking for leads, investment insights, or competitive intelligence?
News about Regeneron Pharmaceuticals
Scientists are ready to move an experimental treatment into phase 1 trials.
“We should only be working on two things, health and the freaking environment.”
But Dupixent's high cost could be a problem.
They say a robust review process is needed to convince doctors and insurers new drugs have value.